Espansione Group’s eye-light® Expands Its Horizons: New CE (MDR) Mark for Corneal and Retinal Care
Espansione Group (Zona Artigianale Funo BO, Italy), a leader in medtech innovation in ophthalmology, announced today a major milestone for…
Faricimab – The Fight Against Retinal Diseases
Faricimab (Vabysmo) is the first approved bispecific antibody uniquely engineered to block two key pathways driving retinal vascular disease by…
latest posts
